302 related articles for article (PubMed ID: 28069625)
1. Cost-effectiveness of a pragmatic structured education intervention for the prevention of type 2 diabetes: economic evaluation of data from the Let's Prevent Diabetes cluster-randomised controlled trial.
Leal J; Ahrabian D; Davies MJ; Gray LJ; Khunti K; Yates T; Gray AM
BMJ Open; 2017 Jan; 7(1):e013592. PubMed ID: 28069625
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of the SLIMMER diabetes prevention intervention in Dutch primary health care: economic evaluation from a randomised controlled trial.
Duijzer G; Bukman AJ; Meints-Groenveld A; Haveman-Nies A; Jansen SC; Heinrich J; Hiddink GJ; Feskens EJM; de Wit GA
BMC Health Serv Res; 2019 Nov; 19(1):824. PubMed ID: 31711499
[TBL] [Abstract][Full Text] [Related]
3. Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis.
Gillett M; Dallosso HM; Dixon S; Brennan A; Carey ME; Campbell MJ; Heller S; Khunti K; Skinner TC; Davies MJ
BMJ; 2010 Aug; 341():c4093. PubMed ID: 20729270
[TBL] [Abstract][Full Text] [Related]
4. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study.
Christie D; Thompson R; Sawtell M; Allen E; Cairns J; Smith F; Jamieson E; Hargreaves K; Ingold A; Brooks L; Wiggins M; Oliver S; Jones R; Elbourne D; Santos A; Wong IC; O'Neill S; Strange V; Hindmarsh P; Annan F; Viner R
Health Technol Assess; 2014 Mar; 18(20):1-202. PubMed ID: 24690402
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness of Facilitated Access to a Self-Management Website, Compared to Usual Care, for Patients With Type 2 Diabetes (HeLP-Diabetes): Randomized Controlled Trial.
Li J; Parrott S; Sweeting M; Farmer A; Ross J; Dack C; Pal K; Yardley L; Barnard M; Hudda M; Alkhaldi G; Murray E
J Med Internet Res; 2018 Jun; 20(6):e201. PubMed ID: 29884608
[TBL] [Abstract][Full Text] [Related]
6. Economic evaluation of a brief education, self-management and upper limb exercise training in people with rheumatoid arthritis (EXTRA) programme: a trial-based analysis.
Manning VL; Kaambwa B; Ratcliffe J; Scott DL; Choy E; Hurley MV; Bearne LM
Rheumatology (Oxford); 2015 Feb; 54(2):302-9. PubMed ID: 25173349
[TBL] [Abstract][Full Text] [Related]
7. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of a community-delivered multicomponent intervention compared with enhanced standard care of obese adolescents: cost-utility analysis alongside a randomised controlled trial (the HELP trial).
Panca M; Christie D; Cole TJ; Costa S; Gregson J; Holt R; Hudson LD; Kessel AS; Kinra S; Mathiot A; Nazareth I; Wataranan J; Wong ICK; Viner RM; Morris S
BMJ Open; 2018 Feb; 8(2):e018640. PubMed ID: 29449292
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of insulin pumps compared with multiple daily injections both provided with structured education for adults with type 1 diabetes: a health economic analysis of the Relative Effectiveness of Pumps over Structured Education (REPOSE) randomised controlled trial.
Pollard DJ; Brennan A; Dixon S; Waugh N; Elliott J; Heller S; Lee E; Campbell M; Basarir H; White D;
BMJ Open; 2018 Apr; 8(4):e016766. PubMed ID: 29627802
[TBL] [Abstract][Full Text] [Related]
10. A multicentred randomised controlled trial of a primary care-based cognitive behavioural programme for low back pain. The Back Skills Training (BeST) trial.
Lamb SE; Lall R; Hansen Z; Castelnuovo E; Withers EJ; Nichols V; Griffiths F; Potter R; Szczepura A; Underwood M;
Health Technol Assess; 2010 Aug; 14(41):1-253, iii-iv. PubMed ID: 20807469
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of a primary healthcare intervention to treat male lower urinary tract symptoms: the TRIUMPH cluster randomised controlled trial.
Cochrane M; Drake MJ; Worthington J; Frost J; Cotterill N; Fader M; McGeagh L; Hashim H; Lane A; Macaulay M; MacNeill S; Rees J; Ridd MJ; Robles LA; Sanderson E; Taylor G; Taylor J; Noble S
BMJ Open; 2024 Jan; 14(1):e075704. PubMed ID: 38296301
[TBL] [Abstract][Full Text] [Related]
12. Engagement, Retention, and Progression to Type 2 Diabetes: A Retrospective Analysis of the Cluster-Randomised "Let's Prevent Diabetes" Trial.
Gray LJ; Yates T; Troughton J; Khunti K; Davies MJ;
PLoS Med; 2016 Jul; 13(7):e1002078. PubMed ID: 27404094
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of telehealth for patients with raised cardiovascular disease risk: evidence from the Healthlines randomised controlled trial.
Dixon P; Hollinghurst S; Edwards L; Thomas C; Gaunt D; Foster A; Large S; Montgomery AA; Salisbury C
BMJ Open; 2016 Aug; 6(8):e012352. PubMed ID: 27566642
[TBL] [Abstract][Full Text] [Related]
14. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
[TBL] [Abstract][Full Text] [Related]
15. The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design.
Sun X; Guo L; Shang H; Ren M; Wang Y; Huo D; Lei X; Wang H; Zhai J
Trials; 2015 Nov; 16():496. PubMed ID: 26530718
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial.
Grant A; Wileman S; Ramsay C; Bojke L; Epstein D; Sculpher M; Macran S; Kilonzo M; Vale L; Francis J; Mowat A; Krukowski Z; Heading R; Thursz M; Russell I; Campbell M;
Health Technol Assess; 2008 Sep; 12(31):1-181, iii-iv. PubMed ID: 18796263
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of a lifestyle intervention in preventing Type 2 diabetes.
Irvine L; Barton GR; Gasper AV; Murray N; Clark A; Scarpello T; Sampson M
Int J Technol Assess Health Care; 2011 Oct; 27(4):275-82. PubMed ID: 22004767
[TBL] [Abstract][Full Text] [Related]
18. Let's prevent diabetes: study protocol for a cluster randomised controlled trial of an educational intervention in a multi-ethnic UK population with screen detected impaired glucose regulation.
Gray LJ; Khunti K; Williams S; Goldby S; Troughton J; Yates T; Gray A; Davies MJ;
Cardiovasc Diabetol; 2012 May; 11():56. PubMed ID: 22607160
[TBL] [Abstract][Full Text] [Related]
19. Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation.
Thomas C; Sadler S; Breeze P; Squires H; Gillett M; Brennan A
BMJ Open; 2017 Aug; 7(8):e014953. PubMed ID: 28827235
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
